Status:
COMPLETED
EXCEL Clinical Trial (Universal Registry)
Lead Sponsor:
Abbott Medical Devices
Conditions:
Chronic Coronary Occlusion
Left Main Coronary Artery Disease
Eligibility:
All Genders
18+ years
Brief Summary
The purpose of the Universal Registry is to assess the proportion and reasons for which subjects with angiographically significant ULMCA disease requiring revascularization during the time course of t...
Detailed Description
Approximately 100 consecutive subjects who otherwise meet all enrollment criteria, will be analyzed separately as intermediate lesion subjects, and will be followed through the time of initial treatme...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Subjects who are either not eligible for randomization or for other reasons are not randomized will be consented for the Universal Registry
Exclusion
Key Trial Info
Start Date :
October 1 2010
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
September 1 2012
Estimated Enrollment :
1000 Patients enrolled
Trial Details
Trial ID
NCT01205789
Start Date
October 1 2010
End Date
September 1 2012
Last Update
December 4 2012
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Abbott Vascular
Santa Clara, California, United States, 95054